Pediatric Neurology Briefs (Apr 2014)

Role of PACAP in Migraine Headaches

  • J Gordon Millichap,
  • John J Millichap

DOI
https://doi.org/10.15844/pedneurbriefs-28-4-3
Journal volume & issue
Vol. 28, no. 4
pp. 27 – 28

Abstract

Read online

Investigators at Danish Headache Centre, University of Copenhagen, Glostrup, Denmark, studied the incidence of migraine during and after intravenous infusion of pituitary adenylate cyclase-activating polypeptide-38 (PACAP38) and vasoactive intestinal polypeptide (VIP) in 22 female migraine patients without aura (mean age 24 years [range 19-36]).

Keywords